Exosect Overview

  • Founded
  • 2001
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 20
Employees
  • Latest Deal Type
  • M&A

Exosect General Information

Description

Provider of a proprietary technology platform designed to offer enhanced delivery of biological and synthetic active ingredients. The company's platform helps to eliminate waste, enabling pesticide manufacturers to improve delivery of their formulations and to overcome issues related to pest resistance, regulatory control and residues within the food chain.

Contact Information

Website
www.exosect.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Agricultural Chemicals
Other Industries
Specialty Chemicals
Acquirer
Terramera
Primary Office
  • Leylands Business Park
  • Colden Common, Hampshire
  • Winchester SO21 1TH
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Exosect Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Merger/Acquisition 14-May-2019 Completed Generating Revenue/Not Profitable
16. Bankruptcy: Admin/Reorg 18-Oct-2018 Completed Bankruptcy: Admin/Reorg
15. Grant 13-Jul-2016 000.00 Completed Generating Revenue
14. Later Stage VC 04-Apr-2016 00.000 000.00 000.00 Completed Generating Revenue
13. Later Stage VC 16-Jan-2015 00.000 000.00 000.00 Completed Generating Revenue
12. Later Stage VC 12-Jul-2013 00.000 000.00 000.00 Completed Generating Revenue
11. Grant 25-Jan-2013 000 000.00 Completed Generating Revenue
10. Later Stage VC 01-Jan-2012 00.000 000.00 000.00 Completed Generating Revenue
9. Later Stage VC 29-Jun-2011 $325K $18.6M 000.00 Completed Generating Revenue
8. Grant 31-Oct-2010 $397K $18.2M Completed Generating Revenue
To view Exosect’s complete valuation and funding history, request access »

Exosect Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
D Ordinary 000,000 00.000000 000.00 000.00 00 000.00 00.000
C Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
B2 Ordinary 00,000 00.000000 000.0 000.0 00 000.0 0.000
B Ordinary 125,729 $0.014280 $49.98 $49.98 1x $49.98 19.58%
A Ordinary 67,503 $0.014280 $49.98 $49.98 1x $49.98 10.51%
To view Exosect’s complete cap table history, request access »

Exosect Patents

  • 143

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 16

    Granted

  • 3

    Pending

  • 000

    Expiring in next 12 mo

Exosect Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3533332-A1 Uv resistant biopesticide microparticles Pending 01-Mar-2018 000000000 0
GB-201615711-D0 Coated product form Ceased 15-Sep-2016 000000000
US-20190200644-A1 Coated product form Pending 15-Sep-2016 000000000
EP-3544447-A1 Coated product form Pending 15-Sep-2016 000000000
GB-201610354-D0 Seed coatings comprising pesticide Ceased 14-Jun-2016 A01N25/08
To view Exosect’s complete patent history, request access »

Exosect Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Exosect Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alpina Capital Partners PE/Buyout Minority 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital 000 0000 000000 0
ClearlySo Angel Group Minority 000 0000 000000 0
Entrepreneurs Fund Family Office Minority 000 0000 000000 0
Frog Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial